Another study by Piao et al. shows that anti-vascular endothelial growth factor treatment can induce hypoxic tumor microenvironment (TME) and stimulate myeloid cell infiltration, as well as tumor mesenchymal transition, promoting tumor progression [8]. Here, VEGFA is linked to neoplasm.